In this study, our 3D gravity-driven microfluidic acute hypoxic PT injury platform and novel proliferative potency assay evaluate mesenchymal stem cell exosomes as a potential therapeutic agent for hypoxic AKI.
Funding
TSA-2020-18383 (Hacettepe University Scientific Research Projects Coordination Unit)